Product Information
CRESTOR 40 MG TABLET is a brand product labeled by AstraZeneca Pharmaceuticals LP, priced at $8.8181 per EA under NDC 00310759030. Its NADAC has been published 171 times since Mar 9, 2022.
The High Outlier badge above means this manufacturer's average price in the Rosuvastatin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/1
Manufacturer
AstraZeneca Pharmaceuticals LPNDC
00310759030
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ROSUVASTATIN CALCIUMApproval Type
New Drug (NDA)
FDA Application
NDA021366On Market Since
1/24/2022
Pharmacological Classes
Price Statistics
The NADAC for CRESTOR 40 MG TABLET has been published 171 times since Mar 9, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.8181 per EA |
|---|---|
| All-time high | $8.8505 (Jun 15, 2022) |
| All-time low | $8.8106 (Jun 22, 2022) |
| 52-week high | $8.8346 |
| 52-week low | $8.8158 |
| Median price | $8.8259 |
| Average price | $8.8268 |
| Largest weekly change | -0.5% (Jun 22, 2022) |
| Weeks tracked | 171 |
| Tracking since | Mar 9, 2022 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CRESTOR 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CRESTOR 40 MG TABLET, manufactured by AstraZeneca Pharmaceuticals LP, is $8.8181 per EA (NDC 00310759030), effective Jun 24, 2026.
How has the price of CRESTOR 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for CRESTOR 40 MG TABLET has held within roughly two percent of its current level. It has been tracked across 171 weekly CMS publications since Mar 9, 2022.
What are the highest and lowest recorded NADAC prices for CRESTOR 40 MG TABLET?
Since Mar 9, 2022, the NADAC for CRESTOR 40 MG TABLET has ranged from a low of $8.8106 (Jun 22, 2022) to a high of $8.8505 (Jun 15, 2022), with a median of $8.8259 per EA.
Are there cheaper alternatives to CRESTOR 40 MG TABLET?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ROSUVASTATIN CALCIUM 40 MG TAB, is $0.0621 per EA — about 99% below CRESTOR 40 MG TABLET.
Who manufactures CRESTOR 40 MG TABLET?
CRESTOR 40 MG TABLET (NDC 00310759030) is labeled by AstraZeneca Pharmaceuticals LP, and CMS classifies it as a brand product.
Related Drugs
Same classification